Cardiovascular Disease (CVD) Risk Screening and Dyslipidemia Treatment for Primary Prevention of Atherosclerotic Cardiovascular Disease (ASCVD)

Cardiovascular Disease (CVD) Risk Screening and Dyslipidemia Treatment for Primary Prevention of Atherosclerotic Cardiovascular Disease (ASCVD) is organized by University of Calgary Office of Continuing Medical Education and Professional Development (CME & PD).

Description:
This online, self-paced, CME program has been co-developed by the Cardiovascular Health & Stroke Strategic Clinical Network, and the University of Calgary CME&PD.

The intent of this online CME is to support and educate key providers (ie. Physicians, pharmacists, NPs) with the information needed to engage in lab-based cardiovascular disease (CVD) risk screening and apply appropriate evidence-based treatment to patients for primary prevention of ASCVD.

Learning Objectives:
After completing this course, you will be enabled to:

• Describe the CVD need/opportunity gap in Alberta,
• Understand appropriate CVD risk screening procedures,
• Explain how the lab-based CVD screening tool fits with other provincial reporting and IT processes and procedures (e.g. ASaP, workflow, Netcare, EMRs, CII PAR, MyHealthRecords),
• Apply the Canadian Cardiovascular Society 2021 dyslipidemia guidelines for treatment decisions.